Literature DB >> 30122683

Medication Related Self- efficacy among Linguistically Diverse Patients with Chronic Illnesses.

Ying Zhang, Cam Solomon, Gerardo Moreno, Eva Chang, Elizabeth H Lin, Ron L Johnson, Heidi Berthoud, Leo S Morales.   

Abstract

This study examines medication-related self-efficacy in a linguistically diverse group of patients with diabetes, hypertension, and elevated cholesterol. A telephone survey of 509 adults conducted in six languages (English, Spanish, Korean, Vietnamese, Mandarin, and Cantonese) was analyzed. Self-efficacy was assessed with the overall Medication Understanding and Use Self-Efficacy (MUSE) score and its two subscale scores on taking medication and learning about medications. Compared with English proficient (EP) patients, patients with limited English proficiency (LEP) had a lower mean learning self-efficacy subscale score (LEP: 14.5, EP: 15.4; p<.001) and no difference in the mean taking self-efficacy subscale score (LEP: 14.4, EP: 14.6; p=.40). Receiving verbal medication information (VMI) from providers modified the relationship between LEP status and learning self-efficacy. In conclusion, among patients with chronic illnesses, LEP patients had lower medication-related self-efficacy scores than EP patients, which may put them at greater risk for medication taking errors and lower adherence.

Entities:  

Mesh:

Year:  2018        PMID: 30122683     DOI: 10.1353/hpu.2018.0079

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  1 in total

1.  Trends in the Utilization of Teleneurology and Other Healthcare Resources Prior to and During the COVID-19 Pandemic in an Urban, Tertiary Health System.

Authors:  Benjamin R Kummer; Parul Agarwal; Chloe Sweetnam; Jessica Robinson-Papp; Leah J Blank; Ilana Katz Sand; Georges Naasan; Christina A Palmese; Joohi Jimenez-Shahed; Jihan Grant; Shanna Patterson; Alison Navis; Laura K Stein; Nathalie Jetté
Journal:  Front Neurol       Date:  2022-02-11       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.